About GC Genome
GC Genome is a company founded in 2013.. The company has 125 employees as of December 31, 2024. GC Genome operates in a competitive market with competitors including Foundation Medicine, Personalis, Novogene Corporation, MedGenome and Lantern Pharma, among others.
- Employees 125 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gc Genome Corp.
-
Annual Revenue
$17.56 M (USD)-5.15as on Dec 31, 2024
-
Net Profit
$-854.36 K (USD)-128.49as on Dec 31, 2024
-
EBITDA
$1.27 M (USD)-49.53as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
125
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GC Genome
GC Genome is a publicly listed company on the KRX with ticker symbol 340450 in South Korea, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of GC Genome
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by GC Genome
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GC Genome
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gc Genome Comparisons
Competitors of GC Genome
GC Genome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Foundation Medicine, Personalis, Novogene Corporation, MedGenome and Lantern Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
|
| domain | founded_year | HQ Location |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gc Genome
Frequently Asked Questions about GC Genome
When was GC Genome founded?
GC Genome was founded in 2013.
Who is the current CEO of GC Genome?
Chang-Seok Ki is the current CEO of GC Genome.
How many employees does GC Genome have?
As of Dec 31, 2024, the latest employee count at GC Genome is 125.
What is the annual revenue of GC Genome?
Annual revenue of GC Genome is $17.56M as on Dec 31, 2024.
What does GC Genome do?
GC Genome was founded in 2013 as a developer in the genomics sector. Next-generation sequencing tests are offered for precision oncology, rare diseases, prenatal and neonatal health, gut analysis, and related areas. Operations focus on diagnostic services across multiple disease categories, with leadership provided by CEO Chang-Seok Ki. The company maintains a presence through its domain gc-genome.com.
Who are the top competitors of GC Genome?
GC Genome's top competitors include Foundation Medicine, MedGenome and Personalis.
Is GC Genome publicly traded?
Yes, GC Genome is publicly traded on KRX under the ticker symbol 340450.
What is GC Genome's ticker symbol?
The ticker symbol of GC Genome is 340450 on KRX.